title: Reply to Gaipa et Al.
authors.forename: A J
authors.initials: AJ
authors.lastname: van der Sluijs-Gelling
authors.forename: V H J
authors.initials: VH
authors.lastname: van der Velden
authors.forename: E T J M
authors.initials: ET
authors.lastname: Roeffen
authors.forename: A J P
authors.initials: AJ
authors.lastname: Veerman
authors.forename: E R
authors.initials: ER
authors.lastname: van Wering
mesh_terms: D000951:Antigens, Neoplasm / Q000032:analysis*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D002648:Child; D006801:Humans; D016130:Immunophenotyping; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology
chemical_list: D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor